Literature DB >> 18836929

The use of AlloDerm in the reconstruction of full-thickness eyelid defects.

Sreekumari Pushpoth1, Katya Tambe, Soupramanien Sandramouli.   

Abstract

PURPOSE: To demonstrate the potential for the use of AlloDerm as a posterior lamellar graft in the reconstruction of full-thickness lid defects.
METHOD: In our case series, we evaluated the surgical outcome of three consecutive patients, two with an upper eyelid defect and one with a lower eyelid defect who underwent lid reconstruction using AlloDerm grafts.
RESULTS: AlloDerm was readily taken up into the wound defect, with complete coverage of its bulbar surface by conjunctiva. In all the cases, the cornea was not affected by its contact to the AlloDerm. A mucocutaneous junction formed over the margin of the AlloDerm graft with good cosmesis.
CONCLUSION: AlloDerm has the potential to act as an effective posterior lamellar substitute in situations where there is an adequate amount of skin muscle cover available to drape over it. It is rigid enough to replace tarsus and its structure behaves as a scaffold allowing conjunctiva to readily grow over it.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836929     DOI: 10.1080/01676830802319054

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  3 in total

Review 1.  Stem cells for skin tissue engineering and wound healing.

Authors:  Ming Chen; Melissa Przyborowski; Francois Berthiaume
Journal:  Crit Rev Biomed Eng       Date:  2009

2.  Extensive full-thickness eyelid reconstruction with rotation flaps through "subcutaneous tunnel" and palatal mucosal grafts.

Authors:  Jian-Xia Cheng; Lan Zuo; Xin-Yu Huang; Ji-Zhe Cui; Shuai Wu; Yuan-Yuan Du
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

3.  Delivery of mesenchymal stem cells in biomimetic engineered scaffolds promotes healing of diabetic ulcers.

Authors:  Roland Assi; Trenton R Foster; Hao He; Katerina Stamati; Hualong Bai; Yuegao Huang; Fahmeed Hyder; Douglas Rothman; Chang Shu; Shervanthi Homer-Vanniasinkam; Umber Cheema; Alan Dardik
Journal:  Regen Med       Date:  2016-03-17       Impact factor: 3.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.